PHILADELPHIA--(BUSINESS WIRE)--Ossianix, Inc. today announced a strategic research collaboration with Lundbeck A/S. This collaboration follows a previous investment in 2012. The collaboration uses Ossianix’s innovative single domain antibody platform based on the shark VNAR structure and will focus on two projects.
Help employers find you! Check out all the jobs and post your resume.
